US 11135247
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11135247 (Materials and methods for engineering cells and uses thereof in immuno-oncology) held by CRISPR THERAPEUTICS AG expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K2239/56